Name | Danirixin |
---|---|
Synonyms |
Urea, N-[4-chloro-2-hydroxy-3-[(3S)-3-piperidinylsulfonyl]phenyl]-N'-(3-fluoro-2-methylphenyl)-
1-{4-Chloro-2-hydroxy-3-[(3S)-3-piperidinylsulfonyl]phenyl}-3-(3-fluoro-2-methylphenyl)urea Danirixin GSK1325756 |
Description | Danirixin is a selective, and reversible CXCR2 antagonist, with IC50 of 12.5 nM for CXCL8. |
---|---|
Related Catalog | |
Target |
CXCL8-CXCR2:12.5 nM (IC50) |
In Vitro | Danirixin is a small molecule, CXCR2 antagonist being evaluated as a potential anti-inflammatory medicine[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 533.1±50.0 °C at 760 mmHg |
Molecular Formula | C19H21ClFN3O4S |
Molecular Weight | 441.904 |
Flash Point | 276.2±30.1 °C |
Exact Mass | 441.092529 |
LogP | 3.93 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.638 |
Storage condition | 2-8℃ |